Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Seto

Showing results (131-140 of 235) with videos related to

Pageof 24
Sort By:
Bioconjugate Chemistry|July 1, 1992
Preparation of micelle-forming polymer-drug conjugatesM Yokoyama, G S Kwon, T Okano, et al.
Journal of Virology|December 1, 1992
Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicityM Tashiro, Y Yokogoshi, K Tobita, et al.
Virology|April 1, 1992
Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in miceM Tashiro, J T Seto, S Choosakul, et al.
Brain, Behavior, and Immunity|June 1, 1997
Involvement of central neurotensin in thermoregulatory and neuroimmune function in pregnant rats exposed to heatH Nakamura, T Seto, H Nagase, et al.
Psychoneuroendocrinology|November 5, 1998
Central administration of interleukin-1 beta reduces natural killer cell activity in non-pregnant rats, but not in pregnant ratsH Nakamura, T Seto, K Hatta, et al.
The Journal of General Virology|June 1, 1992
Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in miceM Tashiro, J T Seto, S Choosakul, et al.
Acta Pathologica Japonica|May 1, 1984
Histochemical AMD electron microscopic studies of intercellular matrices of papilloma induced by painting DMBA on the skin of miceM Okada, T Seto, T Chiba, et al.
Archives of Virology|January 1, 1992
Significance of basolateral domain of polarized MDCK cells for Sendai virus-induced cell fusionM Tashiro, M Yamakawa, K Tobita, et al.
Journal of Virology|October 1, 1990
Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cellsM Tashiro, M Yamakawa, K Tobita, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 1, 2019
Lorlatinib for the treatment of patients with non-small cell lung cancerT Akamine, G Toyokawa, T Tagawa, et al.
Pageof 24

Showing results (131-140 of 235) with videos related to

Sort By:
Pageof 24
Bioconjugate Chemistry|July 1, 1992
Preparation of micelle-forming polymer-drug conjugatesM Yokoyama, G S Kwon, T Okano, et al.
Journal of Virology|December 1, 1992
Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicityM Tashiro, Y Yokogoshi, K Tobita, et al.
Virology|April 1, 1992
Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in miceM Tashiro, J T Seto, S Choosakul, et al.
Brain, Behavior, and Immunity|June 1, 1997
Involvement of central neurotensin in thermoregulatory and neuroimmune function in pregnant rats exposed to heatH Nakamura, T Seto, H Nagase, et al.
Psychoneuroendocrinology|November 5, 1998
Central administration of interleukin-1 beta reduces natural killer cell activity in non-pregnant rats, but not in pregnant ratsH Nakamura, T Seto, K Hatta, et al.
The Journal of General Virology|June 1, 1992
Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in miceM Tashiro, J T Seto, S Choosakul, et al.
Acta Pathologica Japonica|May 1, 1984
Histochemical AMD electron microscopic studies of intercellular matrices of papilloma induced by painting DMBA on the skin of miceM Okada, T Seto, T Chiba, et al.
Archives of Virology|January 1, 1992
Significance of basolateral domain of polarized MDCK cells for Sendai virus-induced cell fusionM Tashiro, M Yamakawa, K Tobita, et al.
Journal of Virology|October 1, 1990
Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cellsM Tashiro, M Yamakawa, K Tobita, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 1, 2019
Lorlatinib for the treatment of patients with non-small cell lung cancerT Akamine, G Toyokawa, T Tagawa, et al.
Pageof 24